Clinical Trials Browser

Phase 2/3 × Axitinib × Endocrine × Clear all

NCT01744249 2021-02-02

Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas

Phase 2/3 Unknown

Neuroendocrine Tumors